ArticleVascular health and risk management2007

Short-term effect of the HMG-CoA reductase inhibitor rosuvastatin on erythrocyte nitric oxide synthase activity.

Barbara Ludolph et al.PubMed ↗Full text ↗

No numbers read from the abstract.